These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19151570)

  • 1. [Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation].
    Suga Y; Kumazaki M; Nishigami J; Takeda K; Kawagishi A; Ishizaki J; Inokuchi M; Miyamoto K; Arai K
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):93-6. PubMed ID: 19151570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Promising new injection method to prevent angialgia/phlebitis from epirubicin hydrochloride therapy for breast cancer].
    Ono C; Yamagami M; Kamatani R; Yamamoto M; Mukouyama T; Sugimoto M; Suzuki T; Kamo N; Seki N; Eguchi K; Ikeda T
    Gan To Kagaku Ryoho; 2012 May; 39(5):777-81. PubMed ID: 22584330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of formulation decreases venous irritation in breast cancer patients receiving epirubicin.
    Nagata K; Egashira N; Yamada T; Watanabe H; Yamauchi Y; Oishi R
    Support Care Cancer; 2012 May; 20(5):951-5. PubMed ID: 21519948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous pain and phlebitis caused by epirubicin hydrochloride.
    Sugimoto M; Matsui M; Harada M; Yamauchi Y; Moriyama N; Andou K; Yamamoto M; Yamaoka H; Ono C; Ishikawa M; Kamo N; Ikeda T; Yamaoka K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):969-74. PubMed ID: 19542717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.
    Yoh K; Niho S; Goto K; Ohmatsu H; Kubota K; Kakinuma R; Saijo N; Nishiwaki Y
    Lung Cancer; 2007 Mar; 55(3):337-41. PubMed ID: 17126951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin chemotherapy in women with breast cancer: Alternating arms for intravenous administration to reduce chemical phlebitis.
    Roberts R; Hanna L; Borley A; Dolan G; Williams EM
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13114. PubMed ID: 31148328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of heparin to lower the incidence of phlebitis induced by anti-neoplastic agents used in ovarian cancer.
    Ikeda S; Douchi T; Nagata Y
    J Obstet Gynaecol Res; 2004 Dec; 30(6):427-9. PubMed ID: 15566456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy induced phlebitis experienced by women with breast cancer following administration of epirubicin using a volumetric infusion pump: an observational study.
    Williams N; Williams EM; Roberts R
    Eur J Oncol Nurs; 2023 Jun; 64():102322. PubMed ID: 37141665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion phlebitis in medical and surgical patients in Siriraj Hospital.
    Danchaivijitr S; Srihapol N; Pakaworawuth S
    J Med Assoc Thai; 1995 Jul; 78 Suppl 2():S91-4. PubMed ID: 7561603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical re-evaluation of effects of different treatments to prevent from phlebitis induced by Chansu injection].
    Zhao Y; Hao Z; Zhang H; Shi J; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2803-6. PubMed ID: 22292370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for the development of phlebitis in peripheral infusions].
    Klaver NS; Hermans J; Ulrich C
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):405-9. PubMed ID: 9562775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasculitic condition following instillation of epirubicin hydrochloride in an outpatient chemotherapy].
    Nakazawa Y; Matsubara Y; Suzuki M; Asako E; Honda A
    Gan To Kagaku Ryoho; 2005 Dec; 32 Suppl 1():24-6. PubMed ID: 16422479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer. A Danish Breast Cancer Cooperative Group Study.
    Willemoe GL; Hertel PB; Bartels A; Jensen MB; Balslev E; Rasmussen BB; Mouridsen H; Ejlertsen B; Brünner N
    Eur J Cancer; 2009 Sep; 45(14):2528-36. PubMed ID: 19535243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methods of preventing phlebitis induced by infusion of fosaprepitant].
    Kohno E; Kanematsu S; Okazaki S; Ogata M; Kanemitsu M; Yamashita H; Syuntou K; Sekita M; Nishioka R; Yoshida H
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):323-6. PubMed ID: 25812501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Side-effects of pre-operative epirubicin-paclitaxel therapy in primary breast cancer associated with tumor biology.
    Warm M; Kates R; Thomas A; Fischer T; Harbeck N
    Anticancer Res; 2009 Jul; 29(7):2675-80. PubMed ID: 19596945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.
    Untch M; Möbus V; Kuhn W; Muck BR; Thomssen C; Bauerfeind I; Harbeck N; Werner C; Lebeau A; Schneeweiss A; Kahlert S; von Koch F; Petry KU; Wallwiener D; Kreienberg R; Albert US; Lück HJ; Hinke A; Jänicke F; Konecny GE
    J Clin Oncol; 2009 Jun; 27(18):2938-45. PubMed ID: 19364964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study.
    Uslusoy E; Mete S
    J Am Acad Nurse Pract; 2008 Apr; 20(4):172-80. PubMed ID: 18387013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of add-on devices for the prevention of phlebitis and other complications associated with the use of peripheral catheters in hospitalised adults: a randomised controlled study.
    Martínez JA; Piazuelo M; Almela M; Blecua P; Gallardo R; Rodríguez S; Escalante Z; Robau M; Trilla A
    J Hosp Infect; 2009 Oct; 73(2):135-42. PubMed ID: 19712998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.